
Solecef-TZ 1.125gm Injection
Marketer
Krishgir Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Solecef-TZ 1.125gm Injection
Ceftriaxone/Sulbactam 1.125g injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and propagation. This injectable medication must be administered solely under a physician's guidance. Strict adherence to the prescribed treatment schedule is crucial, completing the full course even with symptom improvement. Premature cessation can compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior physician approval. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't impair driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor might order blood tests and other assessments to monitor the medicine's impact.
Primary Ingredients of Solecef-TZ 1.125gm Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Solecef-TZ 1.125gm Injection
Infections caused by bacteria
Major Benefits of Solecef-TZ 1.125gm Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Solecef-TZ 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Solecef-TZ 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Solecef-TZ 1.125gm Injection works:
The injectable formulation Solecef-TZ (1.125gm) merges Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Solecef-TZ 1.125gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Solecef-TZ (1.125gm) is typically deemed safe for pregnant individuals. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, research involving human subjects is currently insufficient.
Breast feedingCAUTION
The administration of Solecef-TZ 1.125gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Solecef-TZ 1.125gm Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Solecef-TZ 1.125gm Injection administration to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Cefixime/Sulbactam 1.125g injection requires careful administration in patients exhibiting severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for this injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Solecef-TZ 1.125gm Injection :
Omitting a scheduled Solecef-TZ 1.125gm Injection necessitates contacting your physician.
Facts to Know About Solecef-TZ 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
